Patents Represented by Law Firm Millen & White
  • Patent number: 8216546
    Abstract: A crystallized solid, referred to by the name IM-14, which has an X-ray diffraction diagram as provided below, is described. Said solid has a chemical composition that is expressed according to the formula GeO2:nY2O3:pR:qF:wH2O, where R represents one or more organic radical(s), Y represents at least one trivalent element, and F is fluorine.
    Type: Grant
    Filed: October 1, 2007
    Date of Patent: July 10, 2012
    Assignee: IFP Energies Nouvelles
    Inventors: Yannick Lorgouilloux, Jean Louis Paillaud, Philippe Caullet, Joel Patarin, Nicolas Bats
  • Patent number: 8217389
    Abstract: An organic thin film transistor including a substrate having thereon at least three terminals of a gate electrode, a source electrode and a drain electrode, an insulator layer and an organic semiconductor layer, with a current between a source and a drain being controlled upon application of a voltage to the gate electrode, wherein the organic semiconductor layer includes a compound having a specified structure; and an organic thin film light emitting transistor utilizing an organic thin film transistor, wherein the organic thin film transistor is one in which light emission is obtained utilizing a current flowing between the source and the drain, and the light emission is controlled upon application of a voltage to the gate electrode, and is made high with respect to the response speed (driving speed) and has a large ON/OFF ratio, are provided.
    Type: Grant
    Filed: October 10, 2007
    Date of Patent: July 10, 2012
    Assignee: Idemitsu Kosan, Co., Ltd.
    Inventors: Yuki Nakano, Masatoshi Saito, Hiroaki Nakamura
  • Patent number: 8215120
    Abstract: A process for cooling a storage container, in particular a mobile storage container for a cryogenic medium, is described. According to the invention, the following process steps and features are provided: a) Direct or indirect connection of the storage container (S) that is to be cooled to a refrigeration circuit (2-8, V, T, a, a?), b) Whereby a cold medium, which is identical to or different from the medium that is to be stored in the storage container that is to be cooled, circulates in the refrigeration circuit, c) Whereby the cold medium is compressed (V), cooled (E), and expanded (T) to produce cold, and d) At least a partial stream of the cold medium (5, 7) is used for the cooling of the storage container (S) that is to be cooled.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: July 10, 2012
    Assignee: Linde Aktiengesellschaft
    Inventor: Andres Kundig
  • Patent number: 8211948
    Abstract: The present invention relates to a lyophilized nanoemulsion comprising a lipophilic phase and one or more sucrose fatty acid esters, to the nanoemulsion which can be prepared from the lyophilized nanoemulsion by redispersion, and to a process for the preparation of the lyophilized nanoemulsion.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: July 3, 2012
    Assignee: Merck Patent GmbH
    Inventors: Andrea Hanefeld, Martina Schmidt, Simon Geissler, Peter Langguth
  • Patent number: 8211295
    Abstract: Bitumen within raw oilsands may be cracked and fully recovered by light hydrocarbon extraction following exposure to modified natural zeolite catalysts under cracking conditions. The recovered bitumen is reduced in viscosity, with lower boiling point distributions. Effective cracking of oilsands bitumen using economical, abundant and readily disposable natural zeolites represents a significant step towards a waterless and environment friendly extraction process.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: July 3, 2012
    Assignees: The Governors Of The University Of Alberta, Imperial Oil Resource Limited
    Inventors: Steven M. Kuznicki, William C. McCaffrey, Murray R. Gray, James A. Dunn
  • Patent number: 8210204
    Abstract: A socket for a fluid-transfer coupling device (5) that communicates a flow path in the socket with a flow path in a plug (70) since the socket (10) and the plug are connected to each other, includes a mount panel attachment (17) arranged in the vicinity of an entry (19) of the socket allowing the plug to be inserted, and attaching the socket to a mount panel (18) and a support (35) arranged in a different position from the entry and supporting the socket. Consequently, the socket can be stably supported on the mount panel even if the flow rate of fluid is large. It is preferable that at least one part of the socket is constructed in a spigot-and-socket manner.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: July 3, 2012
    Assignee: Surpass Industry Co., Ltd.
    Inventor: Masahiro Hasunuma
  • Patent number: 8211323
    Abstract: The invention relates to a method for the one-sided removal of a doped surface layer on rear sides of crystalline silicon solar wafers. In accordance with the object set, doped surface layers should be able to be removed from rear sides of such solar wafers in a cost-effective manner and with a handling which is gentle on the substrate. In addition, the front side should not be modified. In accordance with the invention, an etching gas is directed onto the rear side surface of silicon solar wafers with a plasma atmospheric pressure.
    Type: Grant
    Filed: June 14, 2006
    Date of Patent: July 3, 2012
    Assignees: Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung E.V., Centrotherm Photovoltaics AG
    Inventors: Moritz Heintze, Rainer Moeller, Harald Wanka, Elena Lopez, Volkmar Hopfe, Ines Dani, Milan Rosina
  • Patent number: 8211513
    Abstract: The present invention relates to liquid-crystalline compounds having at least three fluorine-substituted benzene rings, a terminal trifluoromethyl group and at least one —CF2O— bridge. The invention also relates to liquid-crystalline media prepared therewith and to liquid-crystal display devices (LC displays) containing these media.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: July 3, 2012
    Assignee: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Axel Jansen, Helmut Haensel, Philipp Krattiger, Andreas Taugerbeck, Malgorzata Rillich
  • Patent number: 8211886
    Abstract: Compounds of the formula (I), which are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed for the treatment of tumours.
    Type: Grant
    Filed: August 6, 2008
    Date of Patent: July 3, 2012
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Oliver Schadt, Dieter Dorsch, Frank Stieber, Andree Blaukat
  • Patent number: 8211277
    Abstract: The present invention relates to compounds containing organofluorochlorophosphate anions, the preparation thereof and the use thereof, in particular as ionic liquids.
    Type: Grant
    Filed: December 7, 2007
    Date of Patent: July 3, 2012
    Assignee: Merck Patent GmbH
    Inventors: Nikolai Ignatyev, German Bissky, Helge Willner
  • Patent number: 8207174
    Abstract: This invention relates to novel aryloxypropanolamines. The invention also relates to the pharmaceutically acceptable salts and solvates containing said compounds, methods for the preparation thereof and to respective synthetic intermediates. Said compounds have agonistic activity at ?3 adrenergic receptors and are useful for treatment of ailments influenced by activation of ?3 adrenergic receptors.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: June 26, 2012
    Assignee: 4SC AG
    Inventors: Stefan Tasler, Daniel Vitt, Kristina Wolf, Andrea Aschenbrenner, Peter Ney
  • Patent number: 8206494
    Abstract: The invention concerns a device for air/water extraction by semi-humid electrostatic collection, comprising a chamber (7) containing a discharge electrode (1) for generating an ion flow from an ionized gas accumulation surrounding the discharge electrode (1) and a counter-electrode (2), an inlet (3) for mixing air and aerosol to be extracted which contains liquid or solid particles, a steam supply tube (8) and an outlet (4) for the cleansed air. The invention is characterized in that the device enables steam to be introduce the steam supply tube (8) in the gap between the discharge electrode (1) and the counter-electrode (2) so as to form a steam sheath (10) enclosing the discharge electrode over its entire length, such that the treated air is not steam-saturated.
    Type: Grant
    Filed: July 24, 2006
    Date of Patent: June 26, 2012
    Assignees: CNRS, Commissariat a l'Energie Atomique
    Inventors: Ernest Galbrun, Jean Luc Achard, Yves Fouillet, Raymond Charles
  • Patent number: 8207210
    Abstract: Novel aminoindazolylurea derivatives of the formula I (I), in which R1, R2, R3, R4, R5, X and Y have the meanings indicated in Claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.
    Type: Grant
    Filed: June 18, 2007
    Date of Patent: June 26, 2012
    Assignee: Merck Patent GmbH
    Inventors: Markus Klein, Rolf Gericke, Norbert Beier, Florian Lang
  • Patent number: 8207288
    Abstract: A polycarbonate polymer includes: a monomer unit represented by a formula (1A) below; and a monomer unit represented by a formula (2). A haze of a solution that is obtained by dissolving the polycarbonate polymer in THF (tetrahydrofuran) at a concentration of 10 mass % is 5% or less (according to JIS K7105, optical path length of 10 mm). In the formula (1A), R and R? each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 12 carbon atoms or a substituted or unsubstituted aryl group having 6 to 12 carbon atoms; n1 is an integer in a range of 2 to 4; and n2 is an integer in a range of 25 to 220; and in the formula (2), Ar represents a divalent aromatic group.
    Type: Grant
    Filed: May 7, 2008
    Date of Patent: June 26, 2012
    Assignee: Idemitsu Kosan Co., Ltd.
    Inventor: Takaaki Hikosaka
  • Patent number: 8207150
    Abstract: The 17?-cyano-19-nor-androst-4-ene derivatives of the present invention possess gestagenic activity.
    Type: Grant
    Filed: June 11, 2008
    Date of Patent: June 26, 2012
    Assignee: Bayer Pharma AG
    Inventors: Joachim Kuhnke, Jan Huebner, Rolf Bohlmann, Thomas Frenzel, Ulrich Klar, Frederik Menges, Sven Ring, Steffen Borden, Hans-Peter Muhn, Katja Prelle
  • Patent number: 8207345
    Abstract: Compounds of the formula (I), in which W, R, R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in Claim 1, can be employed, inter alia, for the treatment of tumors.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: June 26, 2012
    Assignee: Merck Patent GmbH
    Inventors: Kai Schiemann, David Bruge, Hans-Peter Buchstaller, Ulrich Emde, Dirk Finsinger, Christiane Amendt, Frank Zenke
  • Patent number: 8207166
    Abstract: The present invention relates to compounds of formula (I), pharmaceutical compositions which contain them and methods for treating cancer using compounds of formula (I).
    Type: Grant
    Filed: November 8, 2010
    Date of Patent: June 26, 2012
    Assignee: Bayer Healthcare LLC
    Inventors: Wendy Lee, Gaetan Ladouceur, Jacques Dumas, Roger Smith, Shihong Ying, Gan Wang, Zhi Chen, Qingjie Liu, Holia Mokdad
  • Patent number: 8202584
    Abstract: Disclosed are a dielectrically negative, liquid-crystalline medium which contains a (first) dielectrically negative component (component A), which contains one or more dielectrically negative compounds of formula I and a further (second) dielectrically negative component (component B), and the use thereof in an electro-optical display, particularly in an active-matrix display based on the VA, ECB, PS-VA, FFS or IPS effect, and displays of this type.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: June 19, 2012
    Assignee: Merck Patent GmbH
    Inventors: Melanie Klasen-Memmer, Axel Jansen, Detlef Pauluth
  • Patent number: 8202882
    Abstract: Novel 5-cyanothienopyridines of the formula (I), in which R1, R2 and R3 have the meanings indicated in claim 1, are inhibitors of TGF-beta receptor kinase, and can be employed, inter alia, for the treatment of tumors.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: June 19, 2012
    Assignee: Merck Patent Gesellschaft MIT Beschränkter Haftung
    Inventors: Guenter Hoelzemann, Ulrich Graedler, Hartmut Greiner, Christiane Amendt, Djordje Musil, Per Hillertz
  • Patent number: D661944
    Type: Grant
    Filed: November 4, 2011
    Date of Patent: June 19, 2012
    Assignee: Joseph Joseph Ltd.
    Inventor: Graeme Davies